[DOI] [PMC free article] [PubMed] [Google Scholar] 9.Chai M, Jiang M, Vergnes L, Fu X, de Barros SC, Doan NB, Huang W, Chu J, Jiao J, Herschman H, et al
doi: 10.1016/j.hbpd.2022.12.004 10 CosarA.OezcanP.TanogluF
Progressive Dosing Protocols Rather than maintaining a static dose throughout a research cycle, progressive protocols involve systematic dose adjustments: Weeks 1-2 : Start at 15mg daily to assess baseline tolerance and response Weeks 3-4 : Increase to 25mg daily if well-tolerated Weeks 5-8 : Potentially increase to 30-35mg based on goals and response Weeks 9-12 : Maintain optimal dose identified during earlier weeks This approach allows for individualized optimization while maintaining safety margins
Finally, how the route of administration and the different forms change the picture
This can cause severe illness and does not make up for the lost time
Neoplastic and preneoplastic lesions induced in female C3H mice by diets containing diethylstilbestrol or 17 beta-estradiol